These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21830731)

  • 21. [Diabetes mellitus of elderly patients: therapeutic recommendations].
    Ben Amara H; Kacem A; Gaigi I; Dakhli S; Ben Mami F; Achour A
    Tunis Med; 2008 Nov; 86(11):957-9. PubMed ID: 19213484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing potential glycemic overtreatment in persons at hypoglycemic risk.
    Tseng CL; Soroka O; Maney M; Aron DC; Pogach LM
    JAMA Intern Med; 2014 Feb; 174(2):259-68. PubMed ID: 24322626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early insulin use in type 2 diabetes: what are the cons?
    Chiasson JL
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S270-4. PubMed ID: 19875563
    [No Abstract]   [Full Text] [Related]  

  • 24. [Critical questions on diabetes therapy and their sequelae. HbA1c: may it be more than 7 after all?].
    Aumiller J
    MMW Fortschr Med; 2009 Oct; 151(42):14-6. PubMed ID: 19938773
    [No Abstract]   [Full Text] [Related]  

  • 25. [Typ 2 diabetes: glucose centered therapy is obsolete].
    Reincke M; Seissler J
    MMW Fortschr Med; 2008 May; 150(18):26-7. PubMed ID: 18533604
    [No Abstract]   [Full Text] [Related]  

  • 26. [Quality of life and problems posed by hypoglycemia in type 2 diabetes mellitus during oral hypoglycemic therapy].
    Ionova TI; Odin VI; Nikitina TP; Kurbatova KA; Shablovskaia NE
    Klin Med (Mosk); 2013; 91(9):34-40. PubMed ID: 24437153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
    Tasci I; Safer U; Naharci I; Sonmez A
    Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of hypoglycemia and its impact on the quality of life (QoL) of type 2 diabetes mellitus patients (The HYPO Study).
    Rombopoulos G; Hatzikou M; Latsou D; Yfantopoulos J
    Hormones (Athens); 2013; 12(4):550-8. PubMed ID: 24457403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of Older Patients With Type 2 Diabetes Mellitus.
    Pratley RE; Rosenstock J; Heller SR; Sinclair A; Heine RJ; Kiljański J; Brusko CS; Duan R; Festa A
    J Diabetes Sci Technol; 2018 Nov; 12(6):1184-1191. PubMed ID: 29893144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of hypoglycaemia in people aged ≥65 years receiving linagliptin: pooled data from 1489 individuals with type 2 diabetes mellitus.
    Nauck M; Araki A; Hehnke U; Plat A; Clark D; Khunti K
    Int J Clin Pract; 2018 Oct; 72(10):e13240. PubMed ID: 30216648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dispelling myths and removing barriers about insulin in type 2 diabetes.
    Meece J
    Diabetes Educ; 2006; 32(1 Suppl):9S-18S. PubMed ID: 16439485
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing hypoglycemia frequency using flash glucose monitoring in older Japanese patients with type 2 diabetes receiving oral hypoglycemic agents.
    Abe H; Shikuma J; Suwanai H; Sano K; Okumura T; Kan K; Takahashi T; Miwa T; Suzuki R; Odawara M
    Geriatr Gerontol Int; 2019 Oct; 19(10):1030-1035. PubMed ID: 31486247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alignment between outcomes and minimal clinically important differences in the Dutch type 2 diabetes mellitus guideline and healthcare professionals' preferences.
    Dankers M; Nelissen-Vrancken MHJMG; Hart BH; Lambooij AC; van Dijk L; Mantel-Teeuwisse AK
    Pharmacol Res Perspect; 2021 May; 9(3):e00750. PubMed ID: 33934550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study finds more fatalities than in lax blood glucose control. Is HbA(1c) of 6.5% too low for the type 2 diabetes patient? (interview by Maria Weiss)].
    Haak T
    MMW Fortschr Med; 2008 Mar; 150(10):17. PubMed ID: 18447283
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiac risk factors and hypoglycemia in an elderly patient: how good is good enough?
    Triplitt C
    Consult Pharm; 2010 Jun; 25 Suppl B():19-27. PubMed ID: 20726379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of the patient with advanced complications, functional decline, and persistent hyperglycemia.
    Zettervall DK
    Consult Pharm; 2010 Jun; 25 Suppl B():5-10. PubMed ID: 20726377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Long acting insulin analogues: results of clinical studies with insulin glargine].
    Fritsche A
    Dtsch Med Wochenschr; 2008 Aug; 133 Suppl 4():S101-5; discussion S124-6. PubMed ID: 18686217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: results from the Indonesian cohort of the A₁chieve study.
    Soewondo P; Lindarto D; Wibisono S; Renaldi O; Dalem-Pemayun TG
    Diabetes Res Clin Pract; 2013 Apr; 100 Suppl 1():S41-6. PubMed ID: 23647718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of type 2 diabetes mellitus in the elderly.
    Soe K; Sacerdote A; Karam J; Bahtiyar G
    Maturitas; 2011 Oct; 70(2):151-9. PubMed ID: 21890292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between HbA1c on target, risk of silent hypoglycemia and glycemic variability in patients with type 2 diabetes mellitus.
    Engler B; Koehler C; Hoffmann C; Landgraf W; Bilz S; Schoner C; Bornstein SR; Hanefeld M
    Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):59-61. PubMed ID: 21246466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.